Kramer Consumer Healthcare

Arcadia Consumer Healthcare, formerly known as Kramer Consumer Healthcare, is a leading consumer healthcare company focused on the acquisition and growth of over-the-counter (OTC) medicines and premium dietary supplements. The company maintains a diverse portfolio of well-recognized brands, including Nizoral for dandruff, Urinozinc for prostate health, Fungi-Nail for anti-fungal treatment, and Kaopectate for digestive health. Following its acquisition by Avista Capital Partners in 2018, the company rebranded and significantly expanded its market presence through strategic brand acquisitions from major pharmaceutical firms like Johnson & Johnson and Sanofi. Arcadia leverages its expertise in marketing, sales, and distribution to revitalize heritage brands and address common consumer health needs. Headquartered in Bridgewater, New Jersey, the company operates primarily in the North American market.